We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

139 hedge funds and large institutions have $962M invested in Dynavax Technologies in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more call options, than puts

Call options by funds: $18.5M | Put options by funds: $8.98M

21% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 39

17% more capital invested

Capital invested by funds: $822M → $962M (+$141M)

6.1% more ownership

Funds ownership: 72.52%78.62% (+6.1%)

4% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 27

1% less funds holding

Funds holding: 140139 (-1)

Holders
139
Holders Change
-1
Holders Change %
-0.71%
% of All Funds
3.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
47
Reduced
39
Closed
27
Calls
$18.5M
Puts
$8.98M
Net Calls
+$9.55M
Net Calls Change
+$2.86M
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$101M +$21.7M +1,255,792 +33%
State Street
2
State Street
Massachusetts
$89.1M -$1.55M -90,043 -2%
BlackRock
3
BlackRock
New York
$76.7M -$157K -9,095 -0.2%
Franklin Resources
4
Franklin Resources
California
$53.3M +$28.1M +1,628,000 +154%
Vanguard Group
5
Vanguard Group
Pennsylvania
$52.6M -$409K -23,679 -0.9%
Federated Hermes
6
Federated Hermes
Pennsylvania
$48.1M -$761K -44,039 -2%
GC
7
GMT Capital
Georgia
$43.9M -$13.1M -756,800 -26%
CCM
8
Consonance Capital Management
New York
$32.9M +$28.6M +1,658,795 New
ACA
9
Avoro Capital Advisors
New York
$32.8M +$28.5M +1,650,700 New
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$32.7M -$190K -11,009 -0.7%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$32.5M -$10.9M -632,400 -28%
SM
12
Senvest Management
New York
$30.4M -$200K -11,601 -0.8%
Deutsche Bank
13
Deutsche Bank
Germany
$28M -$301K -17,432 -1%
HM
14
HealthCor Management
New York
$26.2M +$22.8M +1,318,612 New
William Blair & Company
15
William Blair & Company
Illinois
$24.9M -$12.6M -728,655 -37%
CC
16
Chicago Capital
Illinois
$17.3M +$15.1M +872,658 New
CWG
17
C WorldWide Group
Denmark
$14.7M -$491K -28,426 -4%
Northern Trust
18
Northern Trust
Illinois
$13.6M +$13.9K +806 +0.1%
CLM
19
ClearBridge LLC (Maryland)
Maryland
$12.8M +$1.59M +91,940 +17%
UBS AM
20
UBS AM
Illinois
$11.7M +$9.77M +565,885 +2,276%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$9.85M +$187K +10,851 +2%
PC
22
Polar Capital
United Kingdom
$9.81M -$21.7M -1,255,851 -72%
Citadel Advisors
23
Citadel Advisors
Florida
$9.42M +$4.3M +249,203 +111%
Morgan Stanley
24
Morgan Stanley
New York
$9.06M +$548K +31,756 +7%
FLAM
25
First Light Asset Management
Minnesota
$9.01M +$657K +38,061 +9%

DVAX Hedge Fund Activity: Q1 2018 in Review

139 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2018, worth a combined $962M — up 17% from $822M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new DVAX positions and 27 closed out — a net gain of 1 holder — while 47 added to existing stakes and 39 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $28.6M. The largest seller was Polar Capital, cutting an estimated $21.7M.

  • 139 institutional investors held Dynavax Technologies (DVAX) as of Q1 2018, down from 140 in Q4 2017.
  • Funds reported $962M of Dynavax Technologies stock for Q1 2018, up 17% quarter-over-quarter.
  • 28 funds opened new Dynavax Technologies positions in Q1 2018 and 27 closed out, a net change of +1 holder.
  • The largest Dynavax Technologies buyer in Q1 2018 was Consonance Capital Management, an estimated $28.6M added.
  • The largest Dynavax Technologies seller in Q1 2018 was Polar Capital, an estimated $21.7M sold.

Based on aggregated 13F filings for Q1 2018.